These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2153234)

  • 41. Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B.
    McDermott MR; Graham FL; Hanke T; Johnson DC
    Virology; 1989 Mar; 169(1):244-7. PubMed ID: 2538036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of branched polypeptide carriers on the immunogenicity of predicted epitopes of HSV-1 glycoprotein D.
    Hilbert A; Hudecz F; Mezô G; Mucsi I; Kajtár J; Kurucz I; Gergely J; Rajnavölgyi E
    Scand J Immunol; 1994 Dec; 40(6):609-17. PubMed ID: 7527933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs.
    Ho RJ; Burke RL; Merigan TC
    J Virol; 1989 Jul; 63(7):2951-8. PubMed ID: 2542605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.
    Higgins TJ; Herold KM; Arnold RL; McElhiney SP; Shroff KE; Pachuk CJ
    J Infect Dis; 2000 Nov; 182(5):1311-20. PubMed ID: 11023455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody response to herpes simplex virus glycoprotein D: effects of acyclovir and relation to recurrence.
    Bernstein DI; Stanberry LR; Harrison CJ; Shukla R; Kappes JC; Myers MG
    J Infect Dis; 1987 Sep; 156(3):423-9. PubMed ID: 3039009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.
    Sin JI; Bagarazzi M; Pachuk C; Weiner DB
    DNA Cell Biol; 1999 Oct; 18(10):771-9. PubMed ID: 10541436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
    Eo SK; Lee S; Kumaraguru U; Rouse BT
    Vaccine; 2001 Sep; 19(32):4685-93. PubMed ID: 11535317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity.
    Wu SC; Yu CH; Lin CW; Chu IM
    Vaccine; 2003 Jun; 21(19-20):2516-22. PubMed ID: 12744886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.
    Mester JC; Highlander SL; Osmand AP; Glorioso JC; Rouse BT
    J Virol; 1990 Nov; 64(11):5277-83. PubMed ID: 1698994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.
    Wang L; Sunyer JO; Bello LJ
    J Virol; 2004 Feb; 78(4):1616-22. PubMed ID: 14747527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D.
    Aurelian L; Smith CC; Wachsman M; Paoletti E
    Rev Infect Dis; 1991; 13 Suppl 11():S924-34. PubMed ID: 1664130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.
    Berman PW; Gregory T; Crase D; Lasky LA
    Science; 1985 Mar; 227(4693):1490-2. PubMed ID: 2983428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses.
    Elbahnasawy MA; Donius LR; Reinherz EL; Kim M
    Vaccine; 2018 Oct; 36(41):6191-6201. PubMed ID: 30197285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
    Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
    Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts.
    Krishna S; Blacklaws BA; Overton HA; Bishop DH; Nash AA
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1805-14. PubMed ID: 2544667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Native HSV glycoprotein D subunit vaccine: analysis of in vitro T-cell activation and antigen presentation.
    Ishizaka ST; Mishkin EM
    Viral Immunol; 1991; 4(3):187-93. PubMed ID: 1667262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection.
    Chabalgoity JA; Khan CM; Nash AA; Hormaeche CE
    Mol Microbiol; 1996 Feb; 19(4):791-801. PubMed ID: 8820649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
    Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
    Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Yeast-derived glycoprotein B-1 of herpes simplex virus (HSV) as a candidate for an HSV vaccine.
    Kino Y
    Adv Exp Med Biol; 1990; 278():183-90. PubMed ID: 1963033
    [No Abstract]   [Full Text] [Related]  

  • 60. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.